Wortham Laboratories
Wortham Laboratories is an emerging leader in hemostatic wound healing and coagulation products, with a core flagship product called SeraSeal, the world's first primary hemostatic agent. The company aims to improve surgical efficiency, reduce costs, and enhance patient outcomes through innovative medical devices. With international headquarters in the United States and a global distributor network, Wortham Laboratories is dedicated to developing products that save lives, increase surgical efficiency, and assist first responders.
Industries
Nr. of Employees
small (1-50)
Wortham Laboratories
Products
Primary topical hemostatic agent
A topical hemostatic formulation designed to achieve rapid hemostasis when applied to bleeding wounds in surgical, emergency, and pre-hospital contexts.
Primary topical hemostatic agent
A topical hemostatic formulation designed to achieve rapid hemostasis when applied to bleeding wounds in surgical, emergency, and pre-hospital contexts.
Services
Clinical training and educational resources
Provision of instructional videos, animations, and guidance materials for clinical application of topical hemostatic products.
International distribution and technical support
Management of distribution partners and provision of technical service to support product implementation in multiple countries.
Clinical training and educational resources
Provision of instructional videos, animations, and guidance materials for clinical application of topical hemostatic products.
International distribution and technical support
Management of distribution partners and provision of technical service to support product implementation in multiple countries.
Expertise Areas
- Hemostatic agent development
- Wound care and hemorrhage control
- Clinical training and education
- Clinical product manufacturing
Key Technologies
- Topical hemostatic biomaterials
- Wound sealing and hemostasis formulations
- Clinical training videos and animations
- Comparative clinical benchmarking methods